Lupin Ankleshwar facility wins India Manufacturing Excellence Awards 2019

The 2019 evaluation was done on the basis of an organisations’ Manufacturing Capability, Extended Supply Chain Reliability and Technology Adoption, Lupin said.

Mumbai: Pharma major Lupin Limited recently announced that its Ankleshwar facility has been awarded “Future Ready Factory of the Year | Pharmaceutical Sector, Large Business,” by Frost & Sullivan’s India Manufacturing Excellence Awards (IMEA) 2019.

The 2019 evaluation was done on the basis of an organisations’ Manufacturing Capability, Extended Supply Chain Reliability and Technology Adoption.

On the occasion, Rajendra B Chunodkar, President — Manufacturing Operations, Lupin Limited said, “We are delighted to receive the award for the Future Ready Factory of the Year. We strive to benchmark our manufacturing processes to the best practices in the world and we will continuously strive to get better and emerge successfully in a competitive market.”

Read Also: Lupin to provide access to a latest developments in the field of gastroenterology in India

IMEA was conceptualised with a mission “to recognise Indian Manufacturing capability and assess its global competitiveness” and has been the premier platform to identify Future Ready Factories in the country. The awards recognise best-in-class innovation, success stories and stellar performances exhibited in the manufacturing industry.

Lupin is the eighth largest generics pharmaceutical company by revenues and third-largest Indian pharmaceutical company. For the financial year ended March 31, its consolidated sales and the net profits before exceptional items were at Rs 16,369 crore and Rs 946 crore respectively

Read Also: Lupin unveils generic equivalent of Hectorol Injection